Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection

Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl, Kristine Mørch, Amar P Dhillon, Asa Alsiö, Kristoffer Hellstrand, Johan Westin, Peer Christensen, Peter Leutscher, Gunnar Norkrans, NORDynamIC Study Group

Research output: Contribution to journalComment/debateResearchpeer-review

14 Citations (Scopus)
Original languageEnglish
JournalHepatology
Volume48
Issue number2
Pages (from-to)695
ISSN0270-9139
DOIs
Publication statusPublished - 29 Jul 2008
Externally publishedYes

Keywords

  • Antiviral Agents/administration & dosage
  • Body Weight
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Genotype
  • Hepacivirus/genetics
  • Hepatitis C, Chronic/blood
  • Humans
  • Interferon alpha-2
  • Interferon-alpha/administration & dosage
  • Polyethylene Glycols/administration & dosage
  • RNA, Viral/blood
  • Recombinant Proteins
  • Ribavirin/administration & dosage
  • Time Factors

Cite this